- 期刊
Recanalization Therapies in Acute Ischemic Stroke: Pharmacological Agents, Devices, and Combinations
延伸閱讀
- Wolinski, P., & Glabinski, A. (2013). Chemokines and Neurodegeneration in the Early Stage of Experimental Ischemic Stroke. Mediators of Inflammation, 2013(), 510-518-255. https://doi.org/10.1155/2013/727189
- Hsu, Y. C., Sung, S. F., Ong, C. T., Wu, C. S., & Su, Y. H. (2009). Intravenous Thrombolytic Therapy for Acute Ischemic Stroke: The Experience of a Community Hospital. Acta Neurologica Taiwanica, 18(1), 14-20. https://doi.org/10.29819/ANT.200903.0003
- Gorelick, P. B., & Farooq, M. U. (2013). Advances in Our Understanding of ＂Resistance＂ to Antiplatelet Agents for Prevention of Ischemic Stroke. Stroke Research and Treatment, 2013(), 316-322. https://doi.org/10.1155/2013/727842
- 顏正昌、盧玉強、萬樹人、林清煌、張運德、羅崇誠、陳立偉、高志翔（2010）。Improving Experiences of Thrombolytic Therapy in Acute Ischemic Stroke。重症醫學雜誌，11(4)，231-238。https://doi.org/10.30035/TCCM.201012.0001
- Wartenberg, K. E., Stoll, A., Funk, A., Meyer, A., Schmidt, J. M., & Berrouschot, J. (2011). Infection after Acute Ischemic Stroke: Risk Factors, Biomarkers, and Outcome. Stroke Research and Treatment, 2011(), 442-449. https://doi.org/10.4061/2011/830614